About this episode

Errik Anderson discusses how building better systems for innovation in biotech can reshape healthcare.

What if the biggest breakthroughs in biotech don’t come from more capital—but from building better systems for innovation? In this episode, I sit down with Errik Anderson, biotech entrepreneur and founder behind multiple billion-dollar companies, to discuss how building infrastructure, not just drugs, is reshaping the future of healthcare. Errik explains why most biotech companies fail the same way, how reducing the cost and time of experimentation unlocks more innovation, and why staying private longer enables better long-term decision making. We also explore compounding in biotech, the limits of scaling creativity, and how conviction, mission, and talent ultimately determine which companies change the world.

People in this episode

Host: David Weisburd

Guest: Errik Anderson

Topics covered

• biotech
• innovation
• healthcare
• entrepreneurship
• decision making

Keywords

• biotech
• innovation
• healthcare
• entrepreneurship
• experimentation
• scaling
• decision making

Mentioned in this episode

Organizations: biotech, healthcare

Explore listener stats, chart rankings, contacts and more on the How I Invest with David Weisburd podcast page.